- Needham analyst James Ricchiuti maintained MKS Instruments, Inc MKSI with a Buy and cut the price target from $105 to $95.
- With growing signs of a deepening WFE spending downturn in 2023, he again reduced estimates for MKS, which will report Q3'22 results after the market close on November 2.
- In late September, he issued revised estimates for MKS, including the recently acquired Atotech business and a tempered outlook for the legacy MKS business.
- Since that time, there have been several negative data points, including a preannouncement from Applied Materials, Inc AMAT and a weak 2023 WFE outlook from Lam Research Corp LRCX, both large customers of MKS, along with reports of reduced semi cap-ex from leading semi companies.
- The deteriorating WFE outlook comes at a time of new U.S. export restrictions for U.S. WFE and related parts and services sold in China.
- He re-rated MKS as shares have likely troughed in anticipation of reductions in Street estimates.
- Price Action: MKSI shares traded higher by 0.04% at $77.66 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in